CD8A and neoplasm: These results suggest that anthracyclines promote TA-specific CD8+ T cell proliferation in tumor-draining lymph nodes (TDLNs) and the tumor infiltration of IL-17-producing γδ T cells, followed by the infiltration of activated IFN-γ-producing CD8+ T cells.